HealthNDTV
57 Hearings And An Unanswered Call For Affordable Drugs: Court Seeks Reply
in5points
A breast cancer patient filed a writ petition in the Kerala High Court in 2022 about the high cost of Ribociclib.
The drug Ribociclib is patented and was deemed too expensive and unavailable at an affordable price by the petitioner.
The court has conducted 57 hearings and has now sought a reply on the matter.
The case highlights issues of drug affordability and patent-related barriers in India.
Story angle
Center
L
CL
C
CR
R
Near the middle: closer to straight reporting, less party-line spin.
About how the story is framed, not whether the facts are true.
NDTV
Center-right
Mixed factuality
Who owns this?
Adani Group
Gautam Adani
Acquired by Adani Group in 2022 from the founders.
Wikipedia: Gautam Adani